whatpeptidestostack
← Compound library
BPC-157 and TB-500
Co-administeredThe pairing behind the informal wolverine nickname. Peptara Labs already publishes a page on this pair, so this is a short router card, not a full brief.
How the two mechanisms relate
Neutral. BPC-157, studied in tissue-injury models, and TB-500, a thymosin beta-4 fragment, were co-administered in the cited work, but both sit in tissue-repair research rather than acting on clearly distinct pathways.
This reading describes mechanism and is editorial. The grade above is the published record.
The compounds
BPC-157
A pentadecapeptide studied mostly in animal models of tissue injury. Human evidence is small and uncontrolled, and no regulator has approved it.
Full profile, dosing and safety →TB-500
A short fragment of thymosin beta-4. Almost all outcome data are animal or laboratory, and the one human randomized trial used the full parent peptide, not the fragment.
Full profile, dosing and safety →